Semaglutide is a medication that belongs to the GLP-1 (glucagon-like peptide-1) receptor agonist class
Although your case may be based in Georgia, most Ozempic injury claims are being transferred to the ongoing Ozempic multi-district litigation in the United States District Court for the Eastern District of Pennsylvania
It is not licensed for human consumption or medical use
Seek urgent medical care for severe abdominal pain, persistent vomiting, fainting, breathing difficulty, confusion, signs of severe dehydration, or another possible medical emergency
Pharmacists and pharmacy technicians involved in compounding, compliance, or telehealth services, as well as healthcare professionals interested in GLP-1 and peptide therapies